{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:21:33Z","timestamp":1792624893341,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.femsim.2005.01.010","type":"journal-article","created":{"date-parts":[[2005,2,12]],"date-time":"2005-02-12T12:13:18Z","timestamp":1108210398000},"page":"45-51","source":"Crossref","is-referenced-by-count":13,"title":["Immunization with glutathione<i>S<\/i>-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against<i>Staphylococcus aureus<\/i>infection"],"prefix":"10.1093","volume":"45","author":[{"given":"Jing-Chun","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Liang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Dong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.femsim.2005.01.010-BIB1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/520289","article-title":"Staphylococcus aureus: a well-armed pathogen","volume":"26","author":"Archer","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3168\/jds.S0022-0302(92)77797-2","article-title":"The economic implications of bioengineered mastitis control","volume":"75","author":"Miles","year":"1992","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.femsim.2005.01.010-BIB3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/JB.183.1.63-70.2001","article-title":"Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens","volume":"183","author":"Fitzgerald","year":"2001","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/JCM.31.3.706-707.1993","article-title":"Production of enterotoxins and toxic shock syndrome toxin by bovine mammary isolates of Staphylococcus aureus","volume":"31","author":"Kenny","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB5","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1073\/pnas.092569199","article-title":"Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus","volume":"99","author":"Etz","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.femsim.2005.01.010-BIB6","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1126\/science.284.5419.1523","article-title":"Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen","volume":"284","author":"McKenney","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.femsim.2005.01.010-BIB7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1471-4906(02)02270-6","article-title":"Staphylococcal vaccines","volume":"23","author":"Michie","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/CMR.13.1.16","article-title":"Exotoxins of Staphylococcus aureus","volume":"13","author":"Dinges","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.femsim.2005.01.010-BIB9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/IAI.47.3.598-604.1985","article-title":"Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model","volume":"47","author":"Rasheed","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/IAI.70.2.631-641.2002","article-title":"Relationships between Staphylococcus aureus genetic background, virulence factors, agar groups (alleles), and human disease","volume":"70","author":"Jarraud","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/IAI.69.1.345-352.2001","article-title":"Clonal associations among Staphylococcus aureus isolates from various sites of infection","volume":"69","author":"Booth","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1073\/pnas.87.1.225","article-title":"A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome","volume":"87","author":"Musser","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.femsim.2005.01.010-BIB13","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1067\/mai.2001.117820","article-title":"Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses","volume":"108","author":"Schlievert","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.2185544","article-title":"The staphylococcal enterotoxins and their relatives","volume":"248","author":"Marrack","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.femsim.2005.01.010-BIB15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1084\/jem.167.3.752","article-title":"Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon","volume":"167","author":"Jupin","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.femsim.2005.01.010-BIB16","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/JCM.31.10.2654-2660.1993","article-title":"Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1","volume":"31","author":"Kum","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10408419009105728","article-title":"Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses","volume":"17","author":"Bohach","year":"1990","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/clinids\/16.1.100","article-title":"Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses","volume":"16","author":"Kain","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(08)60534-9","article-title":"Superantigens and their potential role in human disease","volume":"54","author":"Kotzin","year":"1993","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1128\/JCM.23.6.1138-1139.1986","article-title":"Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome","volume":"23","author":"Crass","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/166.4.911","article-title":"Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates","volume":"166","author":"Lee","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB22","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0264-410X(98)00176-5","article-title":"Development of engineered vaccines effective against structurally related bacterial superantigens","volume":"16","author":"Ulrich","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2005.01.010-BIB23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/infdis\/174.2.338","article-title":"Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A","volume":"174","author":"Bavari","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB24","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/IAI.64.8.3007-3015.1996","article-title":"Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures","volume":"64","author":"Neill","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/515250","article-title":"Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors","volume":"177","author":"Woody","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB26","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/IAI.63.6.2141-2146.1995","article-title":"A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation","volume":"63","author":"Cullen","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/IAI.63.2.509-515.1995","article-title":"A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity","volume":"63","author":"Bonventre","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB28","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1084\/jem.181.6.2229","article-title":"Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1","volume":"181","author":"Hurley","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.femsim.2005.01.010-BIB29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/IAI.61.3.793-799.1993","article-title":"Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome","volume":"61","author":"Bonventre","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.64.1.371-374.1996","article-title":"Localization of biologically important regions on toxic shock syndrome toxin 1","volume":"64","author":"Murray","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB31","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1128\/IAI.64.11.4686-4693.1996","article-title":"Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines","volume":"64","author":"Lowell","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB32","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/IAI.64.5.1706-1713.1996","article-title":"Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice","volume":"64","author":"Lowell","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0264-410X(96)00166-1","article-title":"Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model","volume":"15","author":"Woody","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2005.01.010-BIB34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/IAI.63.4.1165-1172.1995","article-title":"Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice","volume":"63","author":"Nakane","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/377308","article-title":"Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection","volume":"188","author":"Hu","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AEM.28.6.946-950.1974","article-title":"Detecting the enterotoxigenicity of Staphylococcus aureus strains","volume":"28","author":"Robbins","year":"1974","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB37","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1128\/IAI.63.4.1229-1234.1995","article-title":"Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model","volume":"63","author":"Stiles","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archinte.1994.00420010044006","article-title":"Gram-positive organisms and sepsis","volume":"154","author":"Bone","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.femsim.2005.01.010-BIB39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0966-842X(96)10021-4","article-title":"The prospects for developing a vaccine against Staphylococcus aureus","volume":"4","author":"Lee","year":"1996","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB40","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1128\/IAI.55.12.3030-3034.1987","article-title":"Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits","volume":"55","author":"Greenberg","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB41","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1172\/JCI1823","article-title":"Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death","volume":"101","author":"Nilsson","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.femsim.2005.01.010-BIB42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11908-000-0009-9","article-title":"Pathogenic mechanisms of enterococcal endocarditis","volume":"2","author":"McCormick","year":"2000","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.femsim.2005.01.010-BIB43","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/IAI.68.6.3630-3634.2000","article-title":"Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals","volume":"68","author":"Schlievert","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB44","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0264-410X(01)00470-4","article-title":"Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome","volume":"20","author":"Gampfer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2005.01.010-BIB45","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/IAI.69.4.2031-2036.2001","article-title":"Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model","volume":"69","author":"Stiles","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB46","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1086\/315023","article-title":"Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity","volume":"180","author":"Nilsson","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB47","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1128\/IAI.70.5.2278-2281.2002","article-title":"Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination","volume":"70","author":"LeClaire","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/AEM.47.2.283-287.1984","article-title":"Development of a monoclonal antibody capable of interacting with five serotypes of Staphylococcus aureus enterotoxin","volume":"47","author":"Meyer","year":"1984","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.femsim.2005.01.010-BIB49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/IAI.56.2.400-404.1988","article-title":"Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies","volume":"56","author":"Bohach","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2005.01.010-BIB50","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/314977","article-title":"Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens","volume":"180","author":"Bavari","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2005.01.010-BIB51","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1086\/320732","article-title":"Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1","volume":"183","author":"Kum","year":"2001","journal-title":"J. Infect. Dis."}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/45\/1\/45\/19167968\/45-1-45.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T19:29:58Z","timestamp":1586114998000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1016\/j.femsim.2005.01.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"URL":"https:\/\/doi.org\/10.1016\/j.femsim.2005.01.010","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}